novexatin
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02343627)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- novexatin
- novexatin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02933879 | Phase 2 | Mar 21, 2016 | Novum Pharmaceutical Research Services, Taro Pharmaceuticals |
| NCT02343627 | Phase 2 | Dec 1, 2014 | Taro Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Taro Pharmaceuticals | For profit | 2 | 2 | 1 | 2014 |
| Novum Pharmaceutical Research Services | For profit | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1